Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Archivos Venezolanos de Farmacologia y Terapeutica(1)
F1000Research(1)
International Journal of Molecular Sciences(1)
Journal of Diabetes Research(1)
Origen
scopus(4)
Non-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusPancreatic beta cell death: Novel potential mechanisms in diabetes therapy
ReviewAbstract: Purpose of Review. Describing the diverse molecular mechanisms (particularly immunological) involvedPalabras claves:Autores:Garicano C.M.D., Martínez M.S., Nava M., Olivar L.C., Palmar J., Rojas M.P., Rojas-Quintero J., Salazar-Vílchez J., Tomey D., Valmore Bermúdez, Velasco M.Fuentes:scopusPrognosis evaluation of ecocardiographic diastolic dysfunction parameters in patients with myocardial infarction with ST elevation
ArticleAbstract: Introduction: Left ventricular diastolic properties are altered in infarcted myocardium. Various metPalabras claves:Diastolic dysfunction, Echo-cardiography, myocardial infarctionAutores:Chaparro R., Doris Anchatuña, Gonzalez R., María García Pacheco, Maritza Torres, Olivar L.C., Ordoñez M.G., Procel X.V., Ramón C.C., Reyes M.G., Rina Ortiz, Rojas M.P., Romero R., Wilson SigüenciaFuentes:scopusThe role of the α cell in the pathogenesis of diabetes: A world beyond the mirror
ReviewAbstract: Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic metabolic disorders, and insuliPalabras claves:glucagon, Hyperglycaemia, Hypoglycaemia, Langerhans’ islets, Type 2 DiabetesAutores:Cabrera De Bravo M.C., Cano-Ponce C., Dávila L.C.A., D’marco L., González M.C., Guerrero-Wyss M., Manzano A., Martínez M.S., Nava M., Olivar L.C., Rina Ortiz, Salazar-Vílchez J., Valmore BermúdezFuentes:scopus